{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:10:39Z","timestamp":1789992639377,"version":"4.0.1"},"reference-count":124,"publisher":"Elsevier","isbn-type":[{"value":"9780443472183","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.08.030","type":"book-chapter","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:15:48Z","timestamp":1788779748000},"page":"127-160","source":"Crossref","is-referenced-by-count":0,"title":["Cannabinoids and therapeutic potential in neuropsychiatry"],"prefix":"10.1016","author":[{"given":"D. Dilara","family":"Ertenu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Papolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyya","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisheva","family":"Wecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Salpekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11481-025-10171-z","article-title":"The effects of cannabinoids on ischemic stroke-associated neuroinflammation: A systematic review","volume":"20","author":"Alraddadi","year":"2025","journal-title":"Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology"},{"key":"10.1016\/bs.irn.2026.08.030_bib2","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","volume":"13","author":"Anand","year":"2020","journal-title":"Journal of Pain Research"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.030_bib3","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1021\/acs.jnatprod.9b00600","article-title":"Pharmacokinetics of phytocannabinoid acids and anticonvulsant effect of cannabidiolic acid in a mouse model of dravet syndrome","volume":"82","author":"Anderson","year":"2019","journal-title":"Journal of Natural Products"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/FBP.0000000000000565","article-title":"Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice","volume":"31","author":"Assareh","year":"2020","journal-title":"Behavioural Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1476-5381.2011.01536.x","article-title":"Themed issue on cannabinoids in biology and medicine","volume":"163","author":"Bab","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.030_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamapsychiatry.2020.0927","article-title":"Association of naturalistic administration of cannabis flower and concentrates with intoxication and impairment","volume":"77","author":"Bidwell","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/pha0000682","article-title":"A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality","volume":"32","author":"Bonn-Miller","year":"2024","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"25","key":"10.1016\/bs.irn.2026.08.030_bib11","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.030_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/bph.13000","article-title":"The phytocannabinoid, \u03949-tetrahydrocannabivarin, can act through 5-HT\u2081A receptors to produce antipsychotic effects","volume":"172","author":"Cascio","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib13","first-page":"211","article-title":"[Legendary Hwa Tuo\u2019s surgery under general anesthesia in the second century China]","volume":"13","author":"Chu","year":"2004","journal-title":"Acta Neurologica Taiwanica"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0b013e31820c23fa","article-title":"An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions","volume":"5","author":"Crean","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1177\/13872877251389608","article-title":"A randomized clinical trial of low-dose cannabis extract in Alzheimer\u2019s disease","volume":"108","author":"Cury","year":"2025","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66879-0","article-title":"Acute effects of cannabigerol on anxiety, stress, and mood: A double-blind, placebo-controlled, crossover, field trial","volume":"14","author":"Cuttler","year":"2024","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.00049.2021","article-title":"Cannabinoid treatments in epilepsy and seizure disorders","volume":"104","author":"Devinsky","year":"2024","journal-title":"Physiological Reviews"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1542\/peds.93.2.254","article-title":"Prenatal marijuana exposure and neonatal outcomes in Jamaica: An ethnographic study","volume":"93","author":"Dreher","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/bs.irn.2026.08.030_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111755","article-title":"The biological potential and health-benefits of flavonoids: A review and development opportunities","volume":"421","author":"Duarte","year":"2025","journal-title":"Chemico-Biological Interactions"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib22","doi-asserted-by":"crossref","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","article-title":"Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats","volume":"295","author":"Duncan","year":"2008","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib23","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1089\/can.2024.0187","volume":"10","author":"Elder","year":"2025","journal-title":"Cannabis & Cannabinoid Research"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1192\/S000712500011503X","article-title":"Working men and ganja: Marihuana use in rural Jamaica. By Melanie Creagan Dreher. Philadelphia: Institute for the Study of Human Issues. 1982. Pp 216. $18.50","volume":"142","author":"Elliott","year":"1983","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/15357597251350031","article-title":"Treating neuropsychiatric conditions in pediatric epilepsy: Practical considerations","volume":"26","author":"Ertenu","year":"2026","journal-title":"Epilepsy Currents"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib26","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamapsychiatry.2019.0076","article-title":"Association of prenatal cannabis exposure with psychosis proneness among children in the adolescent brain cognitive development (ABCD) study","volume":"76","author":"Fine","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tips.2016.12.003","article-title":"Synthetic pot: Not your grandfather\u2019s Marijuana","volume":"38","author":"Ford","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.030_bib28","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41593-019-0512-2","article-title":"Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone","volume":"22","author":"Frau","year":"2019","journal-title":"Nature Neuroscience"},{"key":"10.1016\/bs.irn.2026.08.030_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pediatrneurol.2025.10.013","article-title":"Cannabidiol as adjunctive treatment in drug-resistant epilepsy with epileptic spasms beyond two years of age","volume":"174","author":"Gonz\u00e1lez-Alguacil","year":"2026","journal-title":"Pediatric Neurology"},{"key":"10.1016\/bs.irn.2026.08.030_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2025.106754","article-title":"Linalool in chronic diseases: A comprehensive review of its pharmacological potential and delivery aspects","volume":"185","author":"Goswami","year":"2025","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","article-title":"A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis","volume":"7","author":"Granja","year":"2012","journal-title":"Journal of Neuroimmune Pharmacology: the Official Journal of the Society on NeuroImmune Pharmacology"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071992","article-title":"In vitro model of neuroinflammation: Efficacy of cannabigerol, a non-psychoactive cannabinoid","volume":"19","author":"Gugliandolo","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.08.030_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.pbr.2025.08.014","article-title":"Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers\u2019 mental health: A prospective real-life cohort study","volume":"296","author":"Guimar\u00e3es","year":"2025","journal-title":"Progress in Brain Research"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib34","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/ph3072197","article-title":"Therapeutic potential of non-psychotropic cannabidiol in ischemic stroke","volume":"3","author":"Hayakawa","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.030_bib35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jagp.2019.05.002","article-title":"Randomized placebo-controlled trial of nabilone for agitation in Alzheimer\u2019s disease","volume":"27","author":"Herrmann","year":"2019","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.030_bib36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1528-1167.2010.02523.x","article-title":"\u03949-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats","volume":"51","author":"Hill","year":"2010","journal-title":"Epilepsia"},{"issue":"23","key":"10.1016\/bs.irn.2026.08.030_bib37","article-title":"In vitro and in vivo anti-inflammatory potential of cannabichromene isolated from hemp","volume":"12","author":"Hong","year":"2023","journal-title":"Plants (Basel)"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib38","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/epi.17247","article-title":"Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial","volume":"63","author":"Hurley","year":"2022","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.030_bib39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: Potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: A promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111857","article-title":"Long-term consequences of adolescent exposure to the synthetic cannabinoid AB-FUBINACA in male and female mice","volume":"28","author":"Izquierdo-Luengo","year":"2025","journal-title":"iScience"},{"key":"10.1016\/bs.irn.2026.08.030_bib42","series-title":"Institute of medicine (US)","article-title":"Marijuana and medicine: Assessing the science base","author":"Joy JE","year":"1999"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.030_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/biom15091329","article-title":"Tetrahydrocannabivarin (THCV) dose dependently blocks or substitutes for tetrahydrocannabinol (THC) in a drug discrimination task in rats","volume":"15","author":"Kayir","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/bs.irn.2026.08.030_bib44","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: Their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/bs.irn.2026.08.030_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2026.117850","article-title":"Cannabichromene attenuates fracture pain but impairs bone repair in a murine tibial fracture model","volume":"207","author":"Khajuria","year":"2026","journal-title":"Bone"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076827","article-title":"The cannabinoids, CBDA and THCA, rescue memory deficits and reduce amyloid-beta and tau pathology in an alzheimer\u2019s disease-like mouse model","volume":"24","author":"Kim","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.08.030_bib47","first-page":"623","article-title":"Topical magnesium-coordinated cannabidiolic acid (CBDA) for the treatment of restless leg syndrome","volume":"14","author":"Kimless","year":"2025","journal-title":"Journal of Sleep Disorders and Therapy"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.26142","article-title":"The therapeutic potential of cannabinoids for movement disorders","volume":"30","author":"Kluger","year":"2015","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.irn.2026.08.030_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2022.08.014","article-title":"Cannabinoids in movement disorders","volume":"102","author":"Kluger","year":"2022","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.030_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091398","article-title":"Phytocannabinoids reduce seizures in larval zebrafish and affect endocannabinoid gene expression","volume":"13","author":"Kollipara","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30040867","article-title":"The effects of indirect and direct modulation of endocannabinoid system function on anxiety-related behavior in mice assessed in the elevated plus maze test","volume":"30","author":"Kruk-Slomka","year":"2025","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020340","article-title":"Cannabigerol is a potential therapeutic agent in a novel combined therapy for glioblastoma","volume":"10","author":"Lah","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00952990.2015.1135158","article-title":"Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana","volume":"42","author":"Lauritsen","year":"2016","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.030_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071148","article-title":"Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder (\u2018CUPID\u2019 study): Protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial","volume":"13","author":"Lavender","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.70284","article-title":"Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial","volume":"35","author":"Lavender","year":"2026","journal-title":"Journal of Sleep Research"},{"issue":"22","key":"10.1016\/bs.irn.2026.08.030_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29225471","article-title":"Cannabigerol (CBG): A comprehensive review of its molecular mechanisms and therapeutic potential","volume":"29","author":"Li","year":"2024","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"27","key":"10.1016\/bs.irn.2026.08.030_bib57","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.250659","article-title":"Cannabis and psychosis","volume":"197","author":"Li","year":"2025","journal-title":"CMAJ: Canadian Medical Association Journal = Journal de l\u2019Association Medicale Canadienne"},{"key":"10.1016\/bs.irn.2026.08.030_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123846","article-title":"Cannabidivarin mitigates motor and cognitive impairments in a female mouse model of Rett syndrome","volume":"378","author":"Louren\u00e7o","year":"2025","journal-title":"Life Sciences"},{"issue":"17","key":"10.1016\/bs.irn.2026.08.030_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: A potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.030_bib60","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/can.2016.0032","article-title":"Affinity and efficacy studies of tetrahydrocannabinolic acid a at cannabinoid receptor types one and two","volume":"2","author":"McPartland","year":"2017","journal-title":"Cannabis & Cannabinoid Research"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.030_bib62","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0040-4039(00)90646-4","article-title":"The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish","author":"Mechoulam","year":"1967","journal-title":"Tetrahedron Letters"},{"key":"10.1016\/bs.irn.2026.08.030_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1183019","article-title":"Cannabigerol modulates \u03b1(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat","volume":"14","author":"Mendiguren","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib64","article-title":"Cannabis-Induced acute encephalopathy in a 94-year-old woman due to family administration of cannabidiol (CBD) products: A case report","volume":"15","author":"Moussa","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib65","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.npp.1300047","article-title":"Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): No influence on neuropsychological performance","volume":"28","author":"M\u00fcller-Vahl","year":"2003","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4088\/JCP.v64n0417","article-title":"Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in tourette syndrome: A 6-week randomized trial","volume":"64","author":"M\u00fcller-Vahl","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"23","key":"10.1016\/bs.irn.2026.08.030_bib67","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1111\/bph.14019","article-title":"Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity","volume":"174","author":"Nadal","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2026.08.030_bib68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB(1) and CB(2) receptors and at CB(1)-CB(2) heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2026.08.030_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108250","article-title":"Efficacy of Sativex\u00ae on pain, spasticity, and disability in patients with multiple sclerosis: A systematic review and meta-analysis","volume":"229","author":"Nucera","year":"2026","journal-title":"Pharmacological Research"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacological Reviews"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.030_bib71","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease--successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"The FEBS Journal"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.030_bib72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40263-026-01277-w","article-title":"Efficacy and safety of cannabinoids for neuropsychiatric symptoms of dementia: A systematic review with meta-analysis","volume":"40","author":"Pan","year":"2026","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib73","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.25864","article-title":"Non-motor symptoms in Parkinson\u2019s disease are reduced by nabilone","volume":"88","author":"Peball","year":"2020","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib74","article-title":"Efficacy and safety of cannabinoids for autism spectrum disorder: An updated systematic review","volume":"17","author":"Pereira","year":"2025","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/25785125261421434","article-title":"Cannabinoid hyperemesis syndrome-a survey-based approach to understanding symptoms and cannabis use patterns","volume":"11","author":"Peterson","year":"2026","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/bs.irn.2026.08.030_bib76","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/1934578X1801300922","article-title":"Cannabichromene","volume":"13","author":"Pollastro","year":"2018","journal-title":"Natural Product Communications"},{"issue":"15","key":"10.1016\/bs.irn.2026.08.030_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151927","article-title":"Early administration of the phytocannabinoid cannabidivarin prevents the neurobehavioral abnormalities associated with the Fmr1-KO mouse model of fragile X syndrome","volume":"12","author":"Premoli","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13229-021-00454-6","article-title":"Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin","volume":"12","author":"Pretzsch","year":"2021","journal-title":"Molecular Autism"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41398-019-0654-8","article-title":"Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): A single dose trial during magnetic resonance spectroscopy","volume":"9","author":"Pretzsch","year":"2019","journal-title":"Translational Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2026.08.030_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/neurolint17070107","article-title":"Cognitive effects of cannabis use: A comprehensive review across domains","volume":"17","author":"Queiroz","year":"2025","journal-title":"Neurology International"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063203","article-title":"Beta-caryophyllene, a cannabinoid receptor type 2 selective agonist, in emotional and cognitive disorders","volume":"25","author":"Ricardi","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"16","key":"10.1016\/bs.irn.2026.08.030_bib82","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00213-014-3498-1","article-title":"A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping","volume":"231","author":"Rock","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib83","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bph.12162","article-title":"Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats","volume":"169","author":"Rock","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jagp.2025.10.011","article-title":"A randomized controlled trial of the safety and efficacy of dronabinol for agitation in Alzheimer\u2019s disease","volume":"34","author":"Rosenberg","year":"2026","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2026.08.030_bib85","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cbdv.200790144","article-title":"History of cannabis and its preparations in saga, science, and sobriquet","volume":"4","author":"Russo","year":"2007","journal-title":"Chemistry & Biodiversity"},{"key":"10.1016\/bs.irn.2026.08.030_bib86","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: An ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy & Behavior"},{"issue":"5","key":"10.1016\/bs.irn.2026.08.030_bib87","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/can.2021.0058","article-title":"Survey of patients employing cannabigerol-predominant cannabis preparations: Perceived medical effects, adverse events, and withdrawal symptoms","volume":"7","author":"Russo","year":"2022","journal-title":"Cannabis & Cannabinoid Research"},{"key":"10.1016\/bs.irn.2026.08.030_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/656582","article-title":"Sativex in the management of multiple sclerosis-related spasticity: Role of the corticospinal modulation","volume":"2015","author":"Russo","year":"2015","journal-title":"Neural Plasticity"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.9740\/mhc.2020.11.317","article-title":"Cannabidiol in epilepsy: The indications and beyond","volume":"10","author":"Ryan","year":"2020","journal-title":"Mental Health Clinic"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib90","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv092","article-title":"The CB1 neutral antagonist tetrahydrocannabivarin reduces default mode network and increases executive control network resting state functional connectivity in healthy volunteers","volume":"19","author":"Rzepa","year":"2015","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/15357597241250159","article-title":"Common ground: We can comprehensively treat pediatric epilepsy and psychiatric comorbidities","volume":"24","author":"Salpekar","year":"2024","journal-title":"Epilepsy Currents"},{"issue":"5-6","key":"10.1016\/bs.irn.2026.08.030_bib92","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000481089","article-title":"Dronabinol is a safe long-term treatment option for neuropathic pain patients","volume":"78","author":"Schimrigk","year":"2017","journal-title":"European Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib93","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00414-025-03708-7","article-title":"Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption","volume":"140","author":"Schulte","year":"2026","journal-title":"International Journal of Legal Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2026.08.030_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121603","article-title":"Pharmacokinetics of oral cannabinoid \u03948-tetrahydrocannabivarin and its main metabolites in healthy participants","volume":"17","author":"Sempio","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.124.002166","article-title":"The potential of cannabichromene (CBC) as a therapeutic agent","volume":"391","author":"Sepulveda","year":"2024","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: A case report","volume":"20","author":"Shannon","year":"2016","journal-title":"Permanente Journal"},{"issue":"11","key":"10.1016\/bs.irn.2026.08.030_bib97","doi-asserted-by":"crossref","first-page":"15611","DOI":"10.1007\/s00210-025-04236-2","article-title":"Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: In silico and in vivo explorations","volume":"398","author":"Sharma","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib98","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12967-020-02518-2","article-title":"Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties","volume":"18","author":"Sharpe","year":"2020","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42238-026-00387-y","article-title":"Therapeutic potential of acidic cannabinoids: An update","volume":"8","author":"Singh","year":"2026","journal-title":"Journal of Cannabis Research"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166325","article-title":"Cannabinol modulates neuroprotection and intraocular pressure: A potential multi-target therapeutic intervention for glaucoma","volume":"1868","author":"Somvanshi","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib101","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: Synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.irn.2026.08.030_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111267","article-title":"Vaporized D-limonene selectively mitigates the acute anxiogenic effects of \u03949-tetrahydrocannabinol in healthy adults who intermittently use cannabis","volume":"257","author":"Spindle","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/can.2017.0002","article-title":"Cannabinoids in Parkinson\u2019s disease","volume":"2","author":"Stampanoni Bassi","year":"2017","journal-title":"Cannabis & Cannabinoid Research"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib104","first-page":"243","article-title":"Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: A systematic review","volume":"43","author":"Stella","year":"2021","journal-title":"Trends Psychiatry Psychother"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.toxlet.2012.08.029","article-title":"Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration","volume":"214","author":"Takeda","year":"2012","journal-title":"Toxicology Letters"},{"issue":"4","key":"10.1016\/bs.irn.2026.08.030_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040684","article-title":"Effects of a sativex-like combination of phytocannabinoids on disease progression in R6\/2 mice, an experimental model of Huntington\u2019s disease","volume":"18","author":"Valdeolivas","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.08.030_bib107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuroscience.2020.09.041","article-title":"Chronic treatment with cannabidiolic acid (CBDA) reduces thermal pain sensitivity in male mice and rescues the hyperalgesia in a mouse model of rett syndrome","volume":"453","author":"Vigli","year":"2021","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/bs.irn.2026.08.030_bib108","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/(SICI)1099-1166(199709)12:9<913::AID-GPS663>3.0.CO;2-D","article-title":"Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer\u2019s disease","volume":"12","author":"Volicer","year":"1997","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib109","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/receptors1010002","article-title":"Pharmacology of minor cannabinoids at the cannabinoid CB1 receptor: Isomer- and ligand-dependent antagonism by tetrahydrocannabivarin","volume":"1","author":"Walsh","year":"2022","journal-title":"Receptors"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib111","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200278RR","article-title":"Cannabidivarin alleviates \u03b1-synuclein aggregation via DAF-16 in Caenorhabditis elegans","volume":"37","author":"Wang","year":"2023","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.irn.2026.08.030_bib112","article-title":"Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia","volume":"13","author":"Wang","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.08.030_bib113","article-title":"The antinociceptive activity and mechanism of action of cannabigerol","volume":"158","author":"Wen","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"38","key":"10.1016\/bs.irn.2026.08.030_bib114","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40429-014-0018-7","article-title":"Impact of cannabis use on the development of psychotic disorders","volume":"1","author":"Wilkinson","year":"2014","journal-title":"Current Addiction Reports"},{"issue":"1-2","key":"10.1016\/bs.irn.2026.08.030_bib116","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/bs.irn.2026.08.030_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119829","article-title":"Acute and chronic effects of medicinal cannabis use on anxiety and depression in a prospective cohort of patients new to cannabis","volume":"390","author":"Wolinsky","year":"2025","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/can.2019.0052","article-title":"Use of cannabidiol for the treatment of anxiety: A short synthesis of pre-clinical and clinical evidence","volume":"5","author":"Wright","year":"2020","journal-title":"Cannabis & Cannabinoid Research"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib119","doi-asserted-by":"crossref","DOI":"10.1177\/1934578X20903555","article-title":"Advances in pharmacological activities of terpenoids","volume":"15","author":"Yang","year":"2020","journal-title":"Natural Product Communications"},{"issue":"1-2","key":"10.1016\/bs.irn.2026.08.030_bib120","first-page":"31","article-title":"Synthetic cannabinoids-\u201cSpice\u201d can induce a psychosis: A brief review","volume":"16","author":"Yeruva","year":"2019","journal-title":"Innovations in Clinical Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.08.030_bib121","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.6839","article-title":"Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders","volume":"7","author":"Young-Wolff","year":"2026","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/bs.irn.2026.08.030_bib122","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: Possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2026.08.030_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2026.08.030_bib124","first-page":"463","article-title":"Fifty years of research on cannabidiol (CBD) as an anticonvulsant: The legacy of Brazilian groups","volume":"45","author":"Zuardi","year":"2023","journal-title":"Brazilian Journal of Psychiatry"}],"container-title":["International Review of Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226001303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226001303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:30:23Z","timestamp":1789990223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226001303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443472183"],"references-count":124,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.08.030","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}